Last reviewed · How we verify

NCT04628351

Bladder Training in Radical Prostatectomy

Completed NA Last updated 17 November 2020
What this trial tests

NA trial testing Bladder Training in Urinary Incontinence in 60 participants. Completed in 7 November 2020.

Timeline
10 October 2019
Primary endpoint
10 March 2020
7 November 2020

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment60
Start date10 October 2019
Primary completion10 March 2020
Estimated completion7 November 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Adults 40 to 85, male only, with Urinary Incontinence or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Radical prostatectomy is the gold standard in the treatment of patients with localized prostate cancer. Urinary incontinence, which is common after surgery, can affect the quality of life of men negatively. There are various attempts to prevent and treat urinary symptoms after radical prostatectomy.The aim of this study is to evaluate the effect of the structured bladder training program on lower urinary tract symptoms and quality of life in patients undergoing radical prostatectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Bladder Training

Trials testing the same drug.

Other recruiting trials for Urinary Incontinence

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04628351.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing